Many patient advocates focus on the development and approval of new medicines. Investors typically learn about the pathway to approval via the companies that develop the therapies. However, the opportunity for patient groups and investors to have a dialogue about the challenges that different diseases cause in the day to day lives of families and caregivers is not as frequent. Join this discussion to connect these important groups to talk about the importance of funding development with patients in mind.